AURA - Aura Bio P/S multiplikatori

Aura Biosciences Inc (AURA) tovar belgisi

Aura Biosciences, Inc. (AURA) kompaniyasining normallashtirilgan P/S ko'rsatkichi tuman daromadlariga nisbatan bozor qiymati dinamikasini aks ettiradi, shu bilan birga yangi darajani qayd etmoqda. Aura Biosciences, Inc. (AURA) nufuzli oftalmik onkologlarni birlashtirib, bemorlarning ko'rish qobiliyatini saqlab qolish uchun zarur bo'lgan sharoitlarni yaratadi. Sinov barqarorligi xomashyo ta'minoti ustidan qat'iy nazoratni ta'minlaydi, aniq biofarmatsevtika logistikasi esa uzilishlar xavfini minimallashtirib, barcha tibbiy loyihalar bo'ylab yuqori daromadlilikni qo'llab-quvvatlaydi.

AURA: Aura Biosciences, Inc. P/S multiplikatori 04.07.2022 - 18.11.2026

Aura Biosciences, Inc. (AURA) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:AURA, Aura Biosciences Inc
Aura Corp tayyor mahsulotlari

Aura Biosciences, Inc. (AURA) klinik sinovlarining noaniqligi bilan tavsiflanadigan biofarmatsevtika sektorining xususiyatlari, tushumni biznesning yashab qolishining noyob, ammo muhim ko'rsatkichi qiladi. Ushbu metrika bozor kapitalizatsiyasini haqiqiy savdo hajmlari bilan solishtiradi va narx-savdo nisbati orqali joriy daromadlar nisbatidagi haddan tashqari yuqori baholanganlikni baholash imkonini beradi.

Aura Biosciences, Inc. raqobatchilari

ONC - Sotuvga nisbatan narx|P/S multiplikatori HALO (Halozyme Therapeutics, Inc.)|Revolution Medicines (RVMD) - Sotuvga nisbatan narx|ascentage.com - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati CGON (cgoncology.com)|URGN: P/S multiplikatori|Bicara Therapeutics Inc (BCAX) - P/S multiplikatori|Narxning daromadga nisbati personalis.com|Kapitalizatsiyaning daromadga nisbati Erasca Corp (ERAS)|Kapitalizatsiyaning daromadga nisbati DCTH (Delcath)|Narx/daromad koeffitsiyenti Y-mAbs Therapeutics, Inc.|Candel Therapeutics - Kapitalizatsiyaning daromadga nisbati|Accuray Inc. (ARAY) - Sotuvga nisbatan narx|SELLAS Life Sciences Group, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACTU (Actuate Therapeutics, Inc.)|Citius Oncology (CTOR) - Narxning daromadga nisbati|HURA - Narx/daromad koeffitsiyenti|TARA (Protara Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Fate Therapeutics Inc|P/S multiplikatori WHWK|P/S multiplikatori TScan Therapeutics Inc (TCRX)|Narxning daromadga nisbati championsoncology.com CSBR|XBIT - Kapitalizatsiyaning daromadga nisbati|CVM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati OSTX (OS Therapies)|RADX: P/S multiplikatori|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|ANL (Adlai Nortye) - P/S multiplikatori|P/S multiplikatori verupharma.com|Kapitalizatsiyaning daromadga nisbati TPST (tempesttx.com)|Kapitalizatsiyaning daromadga nisbati Xilio Therapeutics Inc XLO|P/S multiplikatori RENB (Enochian BioSciences)|Mural Bio - Narxning daromadga nisbati|KAPA - Narxning daromadga nisbati|OnKure Therapeutics (OKUR) - Kapitalizatsiyaning daromadga nisbati|GDTC: P/S multiplikatori|Sotuvga nisbatan narx Curis Corp (CRIS)|APLM (apollomicsinc.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tharimmune Corp (THAR)|P/S multiplikatori ADVB|GNPX - Sotuvga nisbatan narx|Narxning daromadga nisbati calidibio.com CLDI|SBFM - Kapitalizatsiyaning daromadga nisbati|XBIO - Narxning daromadga nisbati|SLRX: Narxning daromadga nisbati|Purple Biotech (PPBT) - Narxning daromadga nisbati|AON - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati BGNE|P/S multiplikatori Checkpoint Therapeutics Inc.|P/S multiplikatori ELEV|Kapitalizatsiyaning daromadga nisbati iCAD ICAD|P/S multiplikatori IKNA (Ikena Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd